Drug monitoring of antibiotics in critical care patients - DRAK

Klinikum der Universität MünchenKlinik für Anaesthesiologie0 个研究点目标入组 100 人开始时间: 2012年11月30日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Hospitalisation in the critical care unit of the Department of Anaesthesiology of the University Hospital of Munich
•2. Presence of infection by clinical assessment
•3. Treatment of the patients with one or more of the following antibiotics: piperacillin/tazobactam, cefepime, meropenem, ciprofloxacin, linezolid, colistin
•4. Bolus administration of selected antibiotics
•5. Valid informed consent subscribed by the patient or by his or her legal guardian or - if only a provisional guardian is defined - by the provisional guardian.

•1. Prophylactic antibiotics without clinical assessment for the presence of infection
•2. Planned shorter hospital stay than 4 days
•3. Administration of the selected antibiotic 14 days to 48 hours before the begin of the study
•4. Only a single dose of an antibiotic per day
•5. Subsequent withdrawal of the participation in the study by the patient or the guardian

发起方

Klinikum der Universität MünchenKlinik für Anaesthesiologie